According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings are HK$2.09 Billion. In 2023 the company made an earning of -HK$2.44 Billion, an increase over its 2022 earnings that were of -HK$7.56 Billion. The earnings displayed on this page is the company's Pretax Income.